Your session is about to expire
← Back to Search
Cariprazine for Social Anxiety Disorder
Study Summary
This trial will test whether Vraylar® is an effective, safe, and tolerable treatment for Social Anxiety Disorder. Subjects will be randomly assigned to either take Vraylar® or a placebo for 12 weeks. The study will be conducted at a single clinical research site.
- Social Anxiety Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2011 Phase 3 trial • 497 Patients • NCT01058668Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have taken certain medications called Monoamine Oxidase Inhibitors (MAOIs) within the past 14 days.You have a history of schizophrenia or bipolar disorder.You have a condition called body dysmorphic disorder that affects the way you see and think about your body.You have never had a seizure or a seizure disorder, except for one time when you were a child and had a fever.You have had electro-convulsive therapy (ECT) within the past 12 weeks.You should not be taking any other medications for mental health, such as gabapentin, pregabalin, antipsychotics, SSRIs, SNRIs, benzodiazepines, or other sleep aids, except for zolpidem (Ambien®) which can be taken occasionally for insomnia but not more than 3 times a week.You have a heart condition that is currently diagnosed or has been diagnosed in the past.You have had a problem with drugs or alcohol within the past 24 weeks.
- Group 1: Placebo
- Group 2: Cariprazine
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the current trial still accepting new participants?
"Clinicaltrials.gov states that this clinical trial is not actively recruiting, although it was initially posted on July 15th 2022 and edited most recently on May 17th 2022. However, there are 1227 other medical trials presently seeking patient participants."
Who is the ideal demographic for this research trial?
"This study is actively seeking 40 people with social phobia aged 18 to 65. In order for a participant to be approved, they must comply with the following prerequisites: commit to an effective form of contraception during and up to 4 weeks after the trial ends (condoms, diaphragm etc.), provide written informed consent beforehand; be diagnosed via psychiatric evaluation as having Social anxiety Disorder according DSM-5 criteria and confirmed by Mini International Neuropsychiatric Interview; have total Liebowitz Social Anxiety Scale score of 70 at Screening & Baseline visits; possess Hamilton Depression Rating Scale scores less than 16 respectively on these same dates; present Clinical"
What potential side effects should patients be aware of when taking Cariprazine?
"Cariprazine has already been approved, thus earning a score of 3 in terms of safety."
Can octogenarians participate in this research?
"This trial is only open to individuals aged between 18 and 65. However, there exist 326 medical studies that cater for those below the age of consent and 822 experiments aimed at people above the traditional retirement age."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger